News

Astaxanthin is a natural supplement which has antioxidant activity, supports anti-inflammatory response besides improving skin, muscle and joint health. Cyanotech president and CEO Brent Bailey said the company

The ZuraLac product is a non-iodine based sanitizer targeting dairy mastitis and has been developed to prevent healthcare acquired infections in hospitals and healthcare settings. The company said

The trial comprised 121 patients who were treated with Copaxone, 101 were treated with Betaseron or Rebif (high-dose interferon) and 53 were treated with Avonex (low-dose interferon). The

PAZ320 is a chewable complex carbohydrate-based compound designed to reduce post-meal elevation of blood glucose, as it blocks the action of carbohydrate-hydrolyzing enzymes. The trial will comprise adults

Veeva CRM is said to enable improved customer targeting, increased understanding of customer behavior and enhanced coordination of data between the field force, medical affairs and marketing teams.

The small membrane volume of 0.08 ml reduces material consumption during testing and virus spiking studies to save cost during the initial development phases. Sartobind STIC PA anion-exchange

The companies will make use of Genome-Wide SpliceArray (GWSA) platform by Exonhit to study AD molecular markers associated with clinical parameters. Exonhit’s SpliceArray platform is microarray design that

The company applies its patented Carboxyl Terminal Peptide (CTP) technology and its Reversible Pegylation technology to develop longer-acting, proprietary versions of already approved therapeutic proteins. The CTP technology

Under the acquisition, Shaanxi Weinan’s portfolio of 86 drugs and one health product will be added to the Shaanxi Aoxing’s current drug portfolio. Biostar Pharmaceutical Board chairman and